RespireRx Pharmaceuticals Inc. announced the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of Directors of the Company, effective as of September 30, 2018, the expiration date of his contract. He will remain in these positions until that date. In the future, Dr. Manuso will devote his full time attention to the management of Talfinium Investments Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | +11.11% | +20.00% | +233.33% |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 2.41M | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.52% | 22.66B | |
-11.63% | 16.68B | |
-16.50% | 16.61B | |
-39.57% | 16.92B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- RSPI Stock
- News RespireRx Pharmaceuticals Inc.
- RespireRx Pharmaceuticals Inc. Announces Resignation of James S. Manuso as President, CEO, Vice Chairman and Member of the Board of Directors, Effective September 30, 2018